# Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)

> **NCT07701876** · — · RECRUITING · sponsor: **Ruijin Hospital Luwan Branch** · enrollment: 1740 (estimated)

## Conditions studied

- Heart Failure
- Heart Failure and Reduced Ejection Fraction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07701876
- **Lead sponsor:** Ruijin Hospital Luwan Branch
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 1740 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701876, "Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*